Prismasate Dialysis Solutions for Continuius Renal Replacement Therapy

FDA 510(k) K120333 · Gambro Renal Products

Substantially Equivalent

510(k) numberK120333

Submission

Device name
Prismasate Dialysis Solutions for Continuius Renal Replacement Therapy
Applicant
Gambro Renal Products
Daytona Beach, FL, US
Received
February 3, 2012
Decision date
May 25, 2012
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
KPO – Dialysate Concentrate For Hemodialysis (Liquid Or Powder)
Device class
Class II (moderate risk)
Regulation
21 CFR 876.5820
Specialty
Gastroenterology, Urology
Life-sustaining
Yes

Other 510(k)s with product code KPO

510(k)DeviceApplicantDecision
K260799Nipro Dry Acid Concentrate MixerKPO · Traditional Nipro Technical Solutions, Incoporated08/19/2026SE
K253462NaturaLyte® Dry Bicarbonate Concentrate (08-4112-2)KPO · Traditional Fresenius Medical Care Renal Therapies Group, LLC01/29/2026SE
K252180Bicarby Dialysate RFP-404 (RFP-404-W); Bicarby Dialysate RFP-403 (RFP-403-W); Bicarby…KPO · Traditional Fresenius Medical Care Renal Therapies Group, LLC09/09/2025SE
K243786Bicarby Dialysate RFP-402 (RFP-402-G); Bicarby Dialysate RFP-400 (RFP-400-G); Bicarby…KPO · Traditional Fresenius Medical Care Renal Therapies Group, LLC04/04/2025SE
K240920HemoCare Bicarbonate Concentrate Set (BCS)KPO · Traditional Deka Research and Development07/12/2024SE
K233950pureFLOW 402 (F00012067); pureFLOW 406 (F00012068); pureFLOW 401 (F00012069); pureFLOW…KPO · Traditional Fresenius Medical Care Renal Therapies Group, LLC05/10/2024SE
K233213NxStage PureFlow SolutionKPO · Traditional Nxstage Medical, Inc.01/18/2024SE
K233159pureFLOW 402, pureFLOW 400, pureFLOW 406, pureFLOW 401, pureFLOW 502, pureFLOW 504KPO · Traditional Fresenius Medical Care Renal Therapies Group, LLC12/01/2023SE
K223431Citric Complete Liquid Citric Acid ConcentrateKPO · Traditional Nipro Renal Solutions USA, Corp.08/04/2023SE
K221652NikkicartKPO · Traditional Renal Care Dialysis Solutions, S.A. DE C.V.03/03/2023SE

More from Renal Care Dialysis Solutions, S.A. DE C.V.

510(k)DeviceDecision
K133807Mars Monitor Itc US, Mars Treatment Kit Type 1116/1 - X-Mars US, Prismaflex Control UnitFLD · Traditional 03/26/2014SE
K131516Prismaflex System 7.10KDI · Traditional 01/03/2014SE
K130039Revaclear 300 Dialyzer, Revaclear 400 DialyzerKDI · Traditional 05/02/2013SE
K113313Molecular Adsorbent Recirculating(Mars)FLD · Traditional 12/14/2012SE
K110823PrismaflexKDI · Traditional 06/17/2011SE
K103832Phoenix Hemodialysis Delivery SystemKDI · Traditional 05/20/2011SE
K100451Gamcath High Flow Dolphin MS-GDHC-1315 a; and MS-GDHC-1315J a, Gamcath High Flow Dolphin…MPB · Traditional 12/21/2010SE
K100364Gambro Cartridge Blood Set Low Weight- Low Volume, Model 003422-520FJK · Traditional 11/03/2010SE
K093608Gambro Water Purification Unit, Models Wro 300 and Wro 300 HFIP · Traditional 07/29/2010SE
K080519Prismaflex M150 SetKDI · Traditional 06/13/2008SE

Questions and answers

When was Prismasate Dialysis Solutions for Continuius Renal Replacement Therapy cleared by the FDA?

Prismasate Dialysis Solutions for Continuius Renal Replacement Therapy (K120333) received a 510(k) decision of Substantially Equivalent on May 25, 2012, 112 days after the submission was received.

What is the product code of K120333?

The FDA product code is KPO – Dialysate Concentrate For Hemodialysis (Liquid Or Powder), a Class II (moderate risk) device regulated under 21 CFR 876.5820.